author-photo

Zhiyu Chen

Fudan University

45

Papers

316

Citations

Citation Trend

Filter By

Papers (29) Sort By

Journal Conference Others

Phase III Trial Comparing XELOX Regimen (Oxaliplatin Plus Capecitabine) Versus EOX Regimen (Epirubicin, Oxaliplatin and Capecitabine) as First-Line Treatment for Advanced Gastric Cancer: The EXELOX Trial

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
Regulation of interference-sensitive crossover distribution ensures crossover assurance in Arabidopsis.

2021 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (0)
AKP and GGT level can provide an early prediction of first-line treatment efficacy in colorectal cancer patients with hepatic metastases.

2021 Biomarkers in Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Three-Tier Prognostic Index in Young Adults With Advanced Gastric Cancer.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Correction to: Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer.

2021 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A prospective phase II study of raltitrexed combined with S-1 as salvage treatment for patients with refractory metastatic colorectal cancer.

2021 Asia-pacific Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
XELOX or mFOLFOX6 chemotherapy combined with resection of primary lesion versus chemotherapy alone for colon cancer with unresectable metastases: A randomized clinical trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer.

2020 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (38)
FOLFIRI versus irinotecan monodrug as second-line treatment in metastatic colorectal cancer patients: An open, multicenter, prospective, randomized controlled phase III clinical study.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Impact of cetuximab sequence on progress-free survival (PFS) and overall survival (OS) in patients with RAS wild-type metastatic colorectal cancer (mCRC): A real-world study.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)